OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nitazenes—heralding a second wave for the UK drug-related death crisis?
Adam Holland, Caroline S. Copeland, Gillian W. Shorter, et al.
The Lancet Public Health (2024) Vol. 9, Iss. 2, pp. e71-e72
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The public health risks of counterfeit pills
Joseph Friedman, Daniel Ciccarone
The Lancet Public Health (2025) Vol. 10, Iss. 1, pp. e58-e62
Open Access | Times Cited: 1

Nitazenes represent a growing threat to public health in Europe
Isabelle Giraudon, Katri Abel‐Ollo, Diāna Vanaga-Arāja, et al.
The Lancet Public Health (2024) Vol. 9, Iss. 4, pp. e216-e216
Open Access | Times Cited: 11

In vitro structure–activity relationships and forensic case series of emerging 2-benzylbenzimidazole ‘nitazene’ opioids
Liam M. De Vrieze, Sara E. Walton, Eline Pottie, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 9, pp. 2999-3018
Open Access | Times Cited: 7

'Zombie drugs': Dehumanising news frames and public stigma towards people who use drugs
Harry Sumnall, A.J.A. Holland, AM Atkinson, et al.
International Journal of Drug Policy (2025) Vol. 136, pp. 104714-104714
Open Access

Mortality After Prison Release in England and Wales, 2019-2021: A Comparative Analysis of Cause-Specific Death Rates and Risk Profiles
Karen Slade, Lucy V. Justice, Thom Baguley, et al.
Social Science & Medicine (2025) Vol. 369, pp. 117821-117821
Closed Access

Utilization of drug checking services in Austria: a cross-sectional online survey
Alexandra Karden, Tobias Schiffler, Cornelia Feichtinger, et al.
Harm Reduction Journal (2025) Vol. 22, Iss. 1
Open Access

Identification of nitazene‐related deaths in Australia: How do we make it accurate and timely?
Jennifer Schumann, Jeremy Dwyer, Jared A Brown, et al.
Drug and Alcohol Review (2025)
Closed Access

Field-Portable Device for Detection of Controlled and Psychoactive Substances from e-Cigarettes
Matthew Gardner, Celeste Bowden, Shoaib Manzoor, et al.
ACS Omega (2025)
Open Access

The UHPLC-MS/MS method for the determination of 26 synthetic benzimidazole opioids (nitazene analogs) with isomers separation
Olga Wachełko, Kaja Tusiewicz, Paweł Szpot, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025) Vol. 260, pp. 116796-116796
Closed Access

(Dealing with) Illegal Drugs and “Unwanted Land-Use”: A Socially Inclusive Future Planning Imagination for Drug Consumption Rooms
Philip Boland, Tristan Sturm, Gillian W. Shorter
Journal of Planning Education and Research (2025)
Closed Access

The emergence of nitazenes on the Irish heroin market and national preparation for possible future outbreaks
N. E. B. Killeen, Rodney Lakes, M.H. Webster, et al.
Addiction (2024) Vol. 119, Iss. 9, pp. 1657-1658
Open Access | Times Cited: 3

Testing for protonitazene in human hair using LC–MS-MS
Pascal Kintz, Alice Ameline, Laurie Gheddar, et al.
Journal of Analytical Toxicology (2024) Vol. 48, Iss. 8, pp. 630-635
Closed Access | Times Cited: 3

Identification of 5-aminometonitazene and 5-acetamidometonitazene in a postmortem case: are nitro-nitazenes unstable?
Claire Parks, Peter Maskell, Denise A. McKeown, et al.
Journal of Analytical Toxicology (2024) Vol. 48, Iss. 9, pp. 691-700
Closed Access | Times Cited: 3

Associations among drug acquisition and use behaviors, psychosocial attributes, and opioid-involved overdoses
James A. Swartz, Peipei Zhao, Ross Jacobucci, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Automated detection of controlled substances from sealed e-cigarettes.
Matthew Gardner, Celeste Bowden, Shoaib Manzoor, et al.
(2024)
Open Access | Times Cited: 2

Reframing Dutch drug policies: a new era for harm reduction
Machteld Busz, Katrin Schiffer, Ancella Voets, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2

Europe must continue to lead on harm reduction
B. Kahn, Michel D. Kazatchkine
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1

Illegal synthetic opioids: Can Europe prevent a crisis?
Mafalda Pardal, Elle Wadsworth, Beau Kilmer
RAND Corporation eBooks (2024)
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top